NP
Neena M Patil
EVP & Chief Legal Officer

Neena M Patil insider trades: Jazz Pharmaceuticals (JAZZ) stock sales

EVP & Chief Legal Officer, Jazz Pharmaceuticals Last trade Sep 10, 2026 35 Form 4 filings
$11.2M
Sold, last 12 months
3 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2022
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Neena reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 10, 2026JAZZ↓ Sell$289K
Jun 10, 2026JAZZ↓ Sell$278K
Feb 26, 2026JAZZ↓ Sell$10.7M
Feb 27, 2025JAZZ↓ Sell$551K
Nov 8, 2024JAZZ↓ Sell$457K
May 3, 2024JAZZ↓ Sell$548K
Sep 1, 2023JAZZ↓ Sell$216K
Aug 15, 2023JAZZ↓ Sell$105K
Jun 1, 2023JAZZ↓ Sell$205K
Nov 16, 2022JAZZ↓ Sell$500K
Jun 6, 2022JAZZ↓ Sell$152K
May 6, 2022JAZZ↓ Sell$46K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other JAZZ insiders

Open-market trades in the last 12 months

About Neena M Patil's insider trades

Neena M Patil is EVP & Chief Legal Officer at Jazz Pharmaceuticals (JAZZ). Since May 6, 2022, Neena has reported no open-market purchases and 12 sales worth $14.0M on SEC Form 4. In the last 12 months: 3 sales ($11.2M).

Their filings also include grants and awards (16 filings), shares withheld for taxes (11 filings), shares returned to the company (3 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every JAZZ insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.